000 | 01496 a2200445 4500 | ||
---|---|---|---|
005 | 20250512012346.0 | ||
264 | 0 | _c19890601 | |
008 | 198906s 0 0 eng d | ||
022 | _a0041-1345 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCantarovich, D | |
245 | 0 | 0 |
_aAnti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin. _h[electronic resource] |
260 |
_bTransplantation proceedings _cFeb 1989 |
||
300 |
_a1769-71 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 |
_aAntilymphocyte Serum _xadverse effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCommunicable Diseases _xetiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRabbits _ximmunology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aReceptors, Interleukin-2 _ximmunology |
700 | 1 | _aLe Mauff, B | |
700 | 1 | _aHourmant, M | |
700 | 1 | _aGiral, M | |
700 | 1 | _aDenis, M | |
700 | 1 | _aJacques, Y | |
700 | 1 | _aSoulillou, J P | |
773 | 0 |
_tTransplantation proceedings _gvol. 21 _gno. 1 Pt 2 _gp. 1769-71 |
|
999 |
_c2658471 _d2658471 |